Your vision is our mission.

Cure diseases with advanced biologics – make UGA Biopharma your First CHOice® for your cutting-edge cell lines. We specialize in cost-effective development of high-quality biosimilars and biologics.

Products and Services

We will be happy to answer any questions you may have!

Development of cell lines for the production of biologics and biosimilars is a highly complex process. We will be happy to advise you on any aspect of your project. Just send us a message with your contact details. We will get in touch to arrange a no-obligation consultation for the joint planning of your project.

News Update

>50

customer projects for biologics & biosimilars completed

>20

ready-to-use cell lines developed

>3.5M

liters of media and feeds produced

About us: Your vision is our mission

UGA Biopharma GmbH was established in 2009 in Hennigsdorf near Berlin, Germany. UGA Biopharma specializes in the development of monoclonal cell lines for the production of advanced biologics and biosimilars. Thanks to our technology platform and the expertise of our international team, we are able to deliver top-quality processes rapidly and at low cost. Moreover, our portfolio includes ready-to-use cell lines, which allow our customers to get started quickly in biosimilar development for their own production.

Our own products – with the optimally matched First CHOice® cell culture medium and First CHOice® feeds – offer a high-grade alternative to other commercially available media and feeds. They ensure excellent productivity of our cell lines, as well as high quality of the products.